What is of note is that we observed that breast cancer cells with acquired resistance upregulate interferon signaling pathways and/or TNFα inflammatory signaling, as well as growth factor regulated pathways while downregulating estrogen receptor (ERα), which enable them to overcome the growth inhibition initially brought about by these compounds. Here, ESR1 is linked to breast cancer.